The life sciences industries are highly regulated and competitive. However, there are plenty of opportunities for businesses to improve the health of the world and become successful. Clients require experienced assistance to navigate the critical regulatory, IP, and other legal issues that their organizations are facing – and our team is equipped to do just that.

Tarter Krinsky & Drogin’s Life Sciences Practice brings a global, cross-practice business perspective to guide clients through the complicated legal landscape while reducing their risk exposure. We counsel a broad range of pharmaceutical and biologics companies, device companies, and diagnostic companies on patent issues, the Hatch-Waxman process, trademark and trade dress, and litigation.

We help life science clients maximize the return for their innovations. Our team advises on patent protection, conducts IP audits and product clearances, negotiates license agreements, and prepares opinions. We litigate patent infringement actions before U.S. District Courts and the Federal Circuit, as well as post-grant administrative options before the Patent Trademark Office (PTO) and Federal Trade Commission (FTC).

Partnering with our pharmaceutical and biologics clients, we help them navigate the complicated legal processes relating to their innovations and products. With our team of experienced pharma and biotech patent counselors and litigators, we provide domestic and international clients with advice on market opportunities, portfolio design, formulation development, agreements, Paragraph IV certification, litigation, and settlements.

Based on its deep scientific and engineering knowledge, our Life Sciences Practice represents medical device and scientific instruments companies in their intellectual property and commercial needs. Our lawyers have litigated a wide variety of technologies, and we have counseled on and negotiated a wide variety of agreements.